Pathology of malignant liver tumours;Pathologie der Lebertumoren

Zentralblatt fur Chirurgie

Volumn 125, Issue 7, 2000, Pages 587-591

  Wittekind, Christian ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Differential diagnosis; Etiology; Malignant liver tumours; Pathology

Indexed keywords

ANGIOSARCOMA; BILE DUCT CARCINOMA; HEPATITIS; HEPATOBLASTOMA; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; INTRAHEPATIC BILE DUCT; LEIOMYOSARCOMA; LIVER CARCINOMA; LIVER PARENCHYMA; LIVER TUMOR; NONHODGKIN LYMPHOMA; REVIEW; VIRUS CARRIER;

ADULT; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHILD; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATOBLASTOMA; HUMANS; LIVER; LIVER NEOPLASMS; LYMPHATIC METASTASIS; LYMPHOMA; MALE; PROGNOSIS; SARCOMA;

EID: 0033927288     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Anderson BB, Ukah F, Tette A, Villaflor SG, Koh D, Seton P. Primary tumors of the liver. J Natl Med Assoc 1992; 84: 129-135
2. Anthony PP. Tumors and tumor-like lesions of the liver and biliary tract. In: MacSween RNM, Anthony PP, Scheuer PJ (Eds). Pathology of the liver. 3rd ed. Churchill Livingstone 1994; 635-711
3. Berman MA, Burnham JA, Shehan DG. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Human Pathol 1988; 19: 784-794
4. Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995; 19: 35-41
5. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995; 75(S): 171-190
6. Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980; 46: 372-379
7. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48 900 necropsies. Cancer 1954; 7: 462-503
8. Eggel H. Über das primäre Karzinom der Leber. Beitr Pathol Anat Allg Pathol 1901; 30: 506-604
9. Francis IR, Agha FP, Thompson NW, Keren DF. Fibrolamellar hepatocarcinoma: clinical, radiologic and pathologic features. Gastrointest Radiol 1986; 11: 67-72
10. Haratake J, Hashimoto H. An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma. Liver 1995; 15: 9-15
11. Imazu H, Oichiai M, Funabiki T. Intrahepatic sarcomatous cholangiocarcinoma. J Gastroenterol 1995; 30: 677-682
12. Ito Y, Kojiro M, Nakashima T, Mori T. Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma and hepatic angiosarcoma. Cancer 1988; 62: 1153-1162
13. Kaczynski J, Hansson G, Wallerstedt S. Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area. Br J Cancer 1996; 73: 128-132
14. Kakizoe S, Kojiro M, Nakshima T. Hepatocellular carcinoma with sarcomatous change. Cancer 1987; 59: 310-316
15. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unsusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38: 241-256
16. Kurashima M, Kozuka S, Nakasima N, Hirabayasi N, Ito M. Relationship of intrahepatic bile duct hyperplasia to cholangiocellular carcinoma. Cancer 1988; 61: 2469-2474
17. Maeda T, Adachi E, Kajiyama K, Sugimachi K, Tsuneyoshi M. Spindle cell hepatocellular carcinoma. A clinicopathological analysis of 15 cases. Cancer 1996; 77: 51-57
18. Nagorney DM, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993; 128: 871-877
19. Ohwada S, Yoshihiro O, Iwazuki S, Tanahashi Y, Sawada T, Takeyoshi I, Nakaura S, Iino Y, Morishita Y. Double cancer in different hepatic lobes: hepatocellular and cholangiocellular carcinoma. Hepatogastroenterology 1995; 42: 411-414
20. Oshima A, Tsukama H, Hiyama T, Fujimoto I, Yamano H, Tanaka M. Follow-up study of HBs-Ag positive blood donors with special reference to effect of drinking and smoking on the development of liver cancer. Int J Cancer 1984; 34: 775-779
21. Papotti M, Sambataro D, Marchesa P, Negro F. A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features. Liver 1997; 17: 47-52
22. Penn I. Hepatic transplantation for primary and metastatic cancer of the liver. Surgery 1991; 110: 726-735
23. Ringe B, Wittekind Ch, Bechstein O, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy. Ann Surg 1989; 209: 88-98
24. Ringe B, Pichlmayr R, Wittekind Ch, Tusch G. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270-285
25. Ruck P, Xiao JC, Kaiserling E. Small epithelial cells and the histogenesis of hepatoblastomas. Am J Pathol 1996; 148: 321-329
26. Sallah S, Smith SV, Lony LC, Woodard P, Schmitz JL, Folds JD. Gamma/delta T-cell hepatosplenic lymphoma: a review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia. Ann Hematol 1997; 74: 139-142
27. Stocker JT. Hepatoblastoma. Semin Diagn Pathol 1994; 11: 136-143
28. Tannapfel A, Wasner M, Krause K, Geißler F, Katalinic A, Hauss J, Mössner J, Engeland K, Wittekind Ch. Expression of p73, a novel protein related to the p53 tumor suppressor, and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst 1999; 91: 1154-1158
29. Tannapfel A, Geißler F, Köckerling F, Katalinic K, Hauss J, Wittekind Ch. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma. J Pathol 1999; 187: 439-445
30. Tannapfel A, Engeland K, Weinans L, Katalinic A, Hauss J, Mössner J, Wittekind Ch. Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. Br J Cancer 1999; 80: 1069-1074
31. Thamavit W, Pairojkul C, Tiwawech D, Shirai T, Ito N. Strong promoting effect of Opisthorchis viverrini infection on dimethylnitrosamine-initiated hamset liver. Cancer Lett 1994; 78: 121-125
32. Wittekind Ch, Wagner G (Hrsg). UICC: TNM Klassifikation maligner Tumoren. Springer, Berlin, Heidelberg, New York 1997; 5. Auflage
33. Wada K, Kondo F, Kubosawa H, Kondo Y. Combined hepatocellular and mucinous carcinoma. Acta Pathol Jpn 1986; 36: 285-291
34. Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, Maschek H, Tusch G, Pichlmayr R. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997; 21: 983-990
35. Wittekind Ch. Leberkarzinom: Diagnostische Möglichkeiten und Aussagen der Pathologie. Zentral Chir 1994; 119: 753-758
36. Wittekind Ch. Hepatocellular carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH (Hrsg). UICC: Prognostic factors in cancer. Springer, Berlin, Heidelberg, New York 1995; 88-93
37. Yamada R, Kishi K, Sato M, Sonomura T, Nishida N, Tanaka K, Shioyama Y, Terada M, Kimura M. Transcatheter arterial chemoenbolization (TACE) in the treatment of unresectable liver cancer. World J Surg 1995; 19: 795-800